webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

6-Maleimidohexanoic Acid N-Hydroxysuccinimide Ester

  CAS No.: 55750-63-5   Cat No.: BADC-01500   Purity: ≥98% 4.5  

6-Maleimidohexanoic Acid N-Hydroxysuccinimide Ester is used for preparation of enzyme immunoconjugates and hapten carrier molecule conjugates.

6-Maleimidohexanoic Acid N-Hydroxysuccinimide Ester

Structure of 55750-63-5

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C14H16N2O6
Molecular Weight
308.29
Shipping
Room temperature
Shipping
solvent: -80°C 12 months; Powder: -20°C 3 years

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
100 g $839 In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
6-Maleimidocaproic Acid NHS; EMCS; MDTF
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 6-(2,5-dioxopyrrol-1-yl)hexanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCCCCN2C(=O)C=CC2=O
InChI
InChI=1S/C14H16N2O6/c17-10-5-6-11(18)15(10)9-3-1-2-4-14(21)22-16-12(19)7-8-13(16)20/h5-6H,1-4,7-9H2
InChIKey
VLARLSIGSPVYHX-UHFFFAOYSA-N
Density
1.400±0.10 g/cm<sup>3</sup> (Predicted)
Solubility
DMSO: 500.0 mg/mL (1621.9 mM); Water: insoluble
Melting Point
70-73 °C
Flash Point
244.5±29.3 °C
Index Of Refraction
1.577
PSA
101.06000
Vapor Pressure
0.0±1.2 mmHg at 25°C
Appearance
Off-white to white solid
Quantity
Grams-Kilos
Quality Standard
Enterprise Standard
Shipping
Room temperature
Storage
solvent: -80°C 12 months; Powder: -20°C 3 years
Pictograms
Irritant
Signal Word
Warning
Boiling Point
480.6±47.0 °C (Predicted)
NCT NumberCondition Or DiseasePhaseStart DateSponsorStatus
NCT03600649Ewing SarcomaPhase 12021-09-30Salarius Pharmaceuticals, LLCRecruiting
NCT016592032020-09-03Massachusetts General HospitalRecruiting
NCT04429412Brief Psychotic DisorderNot Applicable2020-06-12Fundaci Sant Joan de DuCompleted
NCT03652272Medication AdherenceNot Applicable2021-10-01Northwestern UniversityRecruiting
NCT00974155DepressionPhase 42015-04-01K. LiebCompleted

6-Maleimidohexanoic Acid N-Hydroxysuccinimide Ester, a versatile chemical reagent with multifaceted biochemical applications, assumes a pivotal role across various fields. Here are four key applications presented with a high degree of perplexity and burstiness:

Protein Labeling: Unveiling its potency in protein labeling, this ester facilitates the attachment of fluorescent dyes, biotin, or other probes to proteins. The maleimide group selectively engages with thiol groups on cysteine residues, while the N-hydroxysuccinimide (NHS) ester interacts with primary amines on lysine residues. This dual reactivity permits precise fluorescent tagging and tracking of proteins in an array of biochemical assays and imaging studies, unveiling novel insights into protein behavior and function.

Antibody Conjugation: In the vast realm of immunochemistry, 6-Maleimidohexanoic Acid NHS Ester stands as an indispensable tool for linking antibodies with enzymes, fluorophores, or other functional molecules. This seamless fusion of antibodies with detection molecules amplifies the sensitivity and specificity of assays like ELISA and western blotting, refining the precision of diagnostic tests and research endeavors. The conjugation process serves as the cornerstone for crafting cutting-edge tools to detect and study biological markers.

Surface Modification: Venturing into the intricate realm of surface modification, 6-Maleimidohexanoic Acid NHS Ester showcases its adaptability by enabling the modification of various surfaces such as nanoparticles, beads, and microarray slides. Through the covalent linkage of ligands or recognition elements to these diverse surfaces, researchers can engineer functionalized platforms for biosensing, diagnostics, and analytical applications.

1.Status of Emergency Contraceptives in Europe One Year after the European Medicines Agency's Recommendation to Switch Ulipristal Acetate to Non-Prescription Status.
Italia S;Brand H Public Health Genomics. 2016;19(4):203-10. doi: 10.1159/000444686. Epub 2016 Mar 30.
BACKGROUND: ;In November 2014, the European Medicines Agency (EMA) recommended switching the emergency contraceptive (EMC) ulipristal acetate to non-prescription status. This study's objective is to assess the current legal status of the two EMCs ulipristal acetate and levonorgestrel in Europe and to report on the development of sales figures for EMCs since they were made freely available.;METHODS: ;Health authorities were contacted in autumn 2015 and asked about the current status of EMCs and whether the sales figures had changed after a switch to non-prescription status. Additionally, data on consumption were collected in 18 German community pharmacies.;RESULTS: ;As of November 2015, most countries in the European Union (EU) have followed the EMA recommendation. Hungary kept the prescription-only status. In Malta, EMC drugs are not authorized. Germany and Croatia switched levonorgestrel to non-prescription status as well. Of the EU candidate and European Free Trade Association countries, ulipristal acetate is available without prescription in Norway and Bosnia and Herzegovina only. Several countries reported an increase in EMC sales since the switch.;CONCLUSIONS: ;An EMA recommendation can strongly contribute to the harmonization of a drug's legal status in the EU.
2.Monitoring of non-point source pollutants load from a mixed forest land use.
Yoon SW;Chung SW;Oh DG;Lee JW J Environ Sci (China). 2010;22(6):801-5.
The aim of this study was to determine the unit load of NPS (non-point source) pollutants including organic variables such as BOD (biochemical oxygen demand), COD (chemical oxygen demand) and DOC (dissolved organic carbon), nitrogen and phosphorus constituents, and suspended solids (SS) and their event mean concentration (EMC) of runoff flows from a water-shed of mixed forest land use by intensive field experiments. Field monitoring for continuous measurements of rainfall, flow, and water quality was conducted over 12 storm events during 2008-2009 using automated and manual sampling methods. The EMCs of individual runoff event were estimated for each water quality constituent based on the flow rate and concentration data of runoff discharge. The average EMCs of BOD, COD, DOC, SS, TN (total nitrogen), NH4(+)-N, NO3(-)-N, TP (total phosphorus), PO4(3-)-P from the mixed forest land were 1.794, 3.498, 1.462, 10.269, 0.862, 0.044, 0.634, 0.034, and 0.005 mg/L, respectively. The annual unit loads of BOD, COD, DOC, SS, TN, NH4(+)-N, NO3(-)-N, TP and PO4(3-)-P were estimated as 66.9, 133.2, 55.5, 429.8, 36.5, 1.6, 26.9, 1.3 and 0.1 kg/(ha x yr), respectively. In addition, affecting parameters on the EMCs were investigated by statistic analysis of the field data.
3.Watershed and land use-based sources of trace metals in urban storm water.
Tiefenthaler LL;Stein ED;Schiff KC Environ Toxicol Chem. 2008 Feb;27(2):277-87. doi: 10.1897/07-126R.1.
Trace metal contributions in urban storm water are of concern to environmental managers because of their potential impacts on ambient receiving waters. The mechanisms and processes that influence temporal and spatial patterns of trace metal loading in urban storm water, however, are not well understood. The goals of the present study were to quantify trace metal event mean concentration (EMC), flux, and mass loading associated with storm water runoff from representative land uses; to compare EMC, flux, and mass loading associated with storm water runoff from urban (developed) and nonurban (undeveloped) watersheds; and to investigate within-storm and within-season factors that affect trace metal concentration and flux. To achieve these goals, trace metal concentrations were measured in 315 samples over 11 storm events in five southern California, USA, watersheds representing eight different land use types during the 2000 through 2005 storm seasons. In addition, 377 runoff samples were collected from 12 mass emission sites (end of watershed) during 15 different storm events. Mean flux at land use sites ranged from 24 to 1,238, 0.1 to 1,272, and 6 to 33,189 g/km(2) for total copper, total lead, and total zinc, respectively.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Sibiromycin | Fmoc-D-Val-Cit-PAB | NHS-SS-biotin | Spliceostatin A | DBCO-PEG4-VA-PBD | Gly-Gly-Gly-PEG4-DBCO | Calicheamicin | N-Me-L-Ala-maytansinol | sulfo-SPDB-DM4 | PSMA-ALB-56 | 6-Maleimidohexanoic Acid N-Hydroxysuccinimide Ester
Send Inquiry
Verification code
Inquiry Basket